Athens Medical C.S.A. (ATH:IATR)

Market Cap	163.50M
Revenue (ttm)	258.36M
Net Income (ttm)	8.08M
Shares Out	86.74M
EPS (ttm)	0.09
PE Ratio	18.03
Forward PE	n/a
Dividend	0.02 (1.06%)
Ex-Dividend Date	Jul 22, 2024

Volume	2,585
Average Volume	7,437
Open	1.905
Previous Close	1.885
Day's Range	1.865 - 1.910
52-Week Range	1.440 - 2.120
Beta	1.16
RSI	44.48
Earnings Date	May 2, 2025

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoul...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,230
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

In 2023, Athens Medical C.S.A.'s revenue was 258.36 million, an increase of 10.69% compared to the previous year's 233.42 million. Earnings were 8.08 million, an increase of 18.05%.